TRAW.NASDAQTraws Pharma, INC

Form 4: Onconova Therapeutics CFO Mark Guerin Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Traws Pharma, INC
🔒Login to Follow

Mark Guerin, CFO and COO of Onconova Therapeutics, reports the acquisition and disposal of common stock and restricted stock units.

Summary

  • On March 13, 2024, Mark Guerin, CFO and COO of Onconova Therapeutics, exercised restricted stock units, converting 8,666 units into common stock.
  • Following this transaction, Mr. Guerin directly owns 38,567 shares of common stock.
  • On March 14, 2024, Mr. Guerin disposed of 2,591 shares of common stock at a price of $0.9.
  • After this disposal, Mr. Guerin directly owns 35,976 shares of common stock.
  • Following the transaction, Mr. Guerin directly owns 17,334 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This is a standard SEC Form 4 filing, which is a routine part of corporate governance and transparency, providing insight into the trading activities of company insiders.

Stakeholder Impact

  • Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value.

Key Dates

DateDescription
03/13/2023Reporting person was granted 26,000 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.
03/13/2024Restricted stock units converted into common stock.
03/14/2024Common stock disposed of.
03/15/2024Date of signature for the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.